Dong‐Ming Kuang

5.8k total citations · 1 hit paper
48 papers, 4.0k citations indexed

About

Dong‐Ming Kuang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dong‐Ming Kuang has authored 48 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 22 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Dong‐Ming Kuang's work include Immune cells in cancer (25 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Immune Cell Function and Interaction (16 papers). Dong‐Ming Kuang is often cited by papers focused on Immune cells in cancer (25 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Immune Cell Function and Interaction (16 papers). Dong‐Ming Kuang collaborates with scholars based in China, United States and Australia. Dong‐Ming Kuang's co-authors include Limin Zheng, Qiyi Zhao, Yan Wu, Peng Chen, Changyou Wu, Xuefeng Li, Jing‐Ping Zhang, Jing Xu, Xiang‐Ming Lao and Wei Yuan and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Dong‐Ming Kuang

45 papers receiving 3.9k citations

Hit Papers

Activated monocytes in peritumoral stroma of hepatocellul... 2009 2026 2014 2020 2009 200 400 600

Peers

Dong‐Ming Kuang
Qiyi Zhao China
Linda Vatan United States
Yibei Zhu China
Su Yin Lim Australia
Qiyi Zhao China
Dong‐Ming Kuang
Citations per year, relative to Dong‐Ming Kuang Dong‐Ming Kuang (= 1×) peers Qiyi Zhao

Countries citing papers authored by Dong‐Ming Kuang

Since Specialization
Citations

This map shows the geographic impact of Dong‐Ming Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Ming Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Ming Kuang more than expected).

Fields of papers citing papers by Dong‐Ming Kuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Ming Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Ming Kuang. The network helps show where Dong‐Ming Kuang may publish in the future.

Co-authorship network of co-authors of Dong‐Ming Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Ming Kuang. A scholar is included among the top collaborators of Dong‐Ming Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Ming Kuang. Dong‐Ming Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mu, Ming, et al.. (2024). Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy. Cancer Research. 84(6). 841–854. 26 indexed citations
2.
Wu, Yan, Dong‐Ming Kuang, & Limin Zheng. (2024). New mechanisms and clinical significance of the modulation of tumor immune environments. Scientia Sinica Vitae. 54(9). 1595–1602.
3.
Wang, Xuyan, Wei Shi, Yingzhe Wang, et al.. (2024). Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma. Cancer Cell. 42(12). 2082–2097.e10. 16 indexed citations
4.
Chen, Zhihang, Xiaoxue Ren, Qian Zhou, et al.. (2023). Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer. Cancer Research. 83(21). 3544–3561. 33 indexed citations
6.
Wang, Xuyan, Wei Yuan, Bo Hu, et al.. (2022). c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Signal Transduction and Targeted Therapy. 7(1). 105–105. 41 indexed citations
7.
Chen, Dong‐Ping, Shi‐Xun Lu, Jinbin Chen, et al.. (2022). PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma. Cancer Research. 82(18). 3307–3320. 12 indexed citations
8.
Fang, Juan, Junyi Guo, Yuan Liao, et al.. (2022). Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications. Science Advances. 8(39). eabo4250–eabo4250. 12 indexed citations
9.
Yuan, Wei, Xiang‐Ming Lao, Dong‐Ping Chen, et al.. (2020). B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis. Science Advances. 6(37). 33 indexed citations
10.
Yuan, Wei, Qiyi Zhao, Zhiliang Gao, et al.. (2019). The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy. Journal of Clinical Investigation. 129(8). 3347–3360. 91 indexed citations
11.
Chen, Minmin, Christos Xiao, Xiang‐Ming Lao, et al.. (2016). Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization. Cancer Discovery. 6(10). 1182–1195. 64 indexed citations
12.
Xiao, Christos, Xiang‐Ming Lao, Minmin Chen, et al.. (2016). PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discovery. 6(5). 546–559. 268 indexed citations
13.
Zhao, Qiyi, Zhanlian Huang, Min He, Zhiliang Gao, & Dong‐Ming Kuang. (2016). BTLA identifies dysfunctional PD-1-expressing CD4+ T cells in human hepatocellular carcinoma. OncoImmunology. 5(12). e1254855–e1254855. 37 indexed citations
14.
Kuang, Dong‐Ming, Christos Xiao, Qiyi Zhao, et al.. (2014). B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. Journal of Clinical Investigation. 124(10). 4657–4667. 68 indexed citations
15.
Wu, Yan, Dong‐Ming Kuang, Weidong Pan, et al.. (2012). Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology. 57(3). 1107–1116. 216 indexed citations
16.
Wu, Yan, Qiyi Zhao, Peng Chen, et al.. (2011). Neutrophils promote motility of cancer cells via a hyaluronan‐mediated TLR4/PI3K activation loop. The Journal of Pathology. 225(3). 438–447. 119 indexed citations
17.
Zhao, Qiyi, Christos Xiao, Yan Wu, et al.. (2011). Interleukin‐17‐educated monocytes suppress cytotoxic T‐cell function through B7‐H1 in hepatocellular carcinoma patients. European Journal of Immunology. 41(8). 2314–2322. 77 indexed citations
18.
Kuang, Dong‐Ming, Peng Chen, Qiyi Zhao, et al.. (2010). Tumor-Activated Monocytes Promote Expansion of IL-17–Producing CD8+ T Cells in Hepatocellular Carcinoma Patients. The Journal of Immunology. 185(3). 1544–1549. 129 indexed citations
19.
Kuang, Dong‐Ming, Qiyi Zhao, Yan Wu, et al.. (2010). Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. Journal of Hepatology. 54(5). 948–955. 401 indexed citations
20.
Kuang, Dong‐Ming, Qiyi Zhao, Jing Xu, et al.. (2008). Tumor-Educated Tolerogenic Dendritic Cells Induce CD3ε Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways. The Journal of Immunology. 181(5). 3089–3098. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026